US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate ...
NKGen Biotech, Inc, a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer cell therapeutics, announced that the US Food and Drug Administration (FDA) has granted fast …